SPYRE THERAPEUTICS, INC. Income Tax Expense
SPYRE THERAPEUTICS, INC. (SYRE) reported Income Tax Expense of $0 for the 3-month period ending 2026-06-30, per its 10-Q filed 2026-08-04.
Financial Statements › Expense Statement › Income Tax
us-gaap:IncomeTaxExpenseBenefit · last filed 2026-08-04
- SPYRE THERAPEUTICS, INC. income tax expense (benefit) for the quarter ending 2026-06-30 was $0.00.
- SPYRE THERAPEUTICS, INC. income tax expense (benefit) for the quarter ending 2026-03-31 was $0.00.
- SPYRE THERAPEUTICS, INC. income tax expense (benefit) for the quarter ending 2025-12-31 was $0.00, a 100.00% decline year-over-year.
- SPYRE THERAPEUTICS, INC. income tax expense (benefit) for the quarter ending 2025-09-30 was $0.00, a 100.00% decline year-over-year.
- SPYRE THERAPEUTICS, INC. income tax expense (benefit) for fiscal 2025 was -$15.00K, a 129.41% decline from fiscal 2024.
- SPYRE THERAPEUTICS, INC. income tax expense (benefit) for fiscal 2024 was $51.00K.
- SPYRE THERAPEUTICS, INC. income tax expense (benefit) for fiscal 2023 was -$26.00K.
- SPYRE THERAPEUTICS, INC. income tax expense (benefit) for fiscal 2022 was -$136.00K, a 196.45% decline from fiscal 2021.
| Period end | Income Tax Expense (Benefit) 3 month | Income Tax Expense (Benefit) 6 month | Income Tax Expense (Benefit) 9 month | Income Tax Expense (Benefit) 12 month |
|---|---|---|---|---|
| 2026-06-30 | $0.00 10-Q · filed 2026-08-04 | $0.00 10-Q · filed 2026-08-04 | $0.00 derived: sum of 3 quarters · filed 2026-08-04 | $0.00 derived: sum of 4 quarters · filed 2026-08-04 |
| 2026-03-31 | $0.00 10-Q · filed 2026-05-05 | $0.00 derived: sum of 2 quarters · filed 2026-05-05 | $0.00 derived: sum of 3 quarters · filed 2026-05-05 | $0.00 derived: sum of 4 quarters · filed 2026-08-04 |
| 2025-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-19 | $0.00 derived: sum of 2 quarters · filed 2026-02-19 | $0.00 derived: sum of 3 quarters · filed 2026-08-04 | -$15.00K 10-K · filed 2026-02-19 |
| 2025-09-30 | $0.00 10-Q · filed 2025-11-04 | $0.00 derived: sum of 2 quarters · filed 2026-08-04 | -$15.00K 10-Q · filed 2025-11-04 | -$14.00K derived: sum of 4 quarters · filed 2026-08-04 |
| 2025-06-30 | $0.00 10-Q · filed 2026-08-04 | -$15.00K 10-Q · filed 2026-08-04 | -$14.00K derived: sum of 3 quarters · filed 2026-08-04 | $4.00K derived: sum of 4 quarters · filed 2026-08-04 |
| 2025-03-31 | -$15.00K 10-Q · filed 2026-05-05 | -$14.00K derived: sum of 2 quarters · filed 2026-05-05 | $4.00K derived: sum of 3 quarters · filed 2026-05-05 | $4.00K derived: sum of 4 quarters · filed 2026-05-05 |
| 2024-12-31 | $1.00K derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-19 | $19.00K derived: sum of 2 quarters · filed 2026-02-19 | $19.00K derived: sum of 3 quarters · filed 2026-02-19 | $51.00K 10-K · filed 2026-02-19 |
| 2024-09-30 | $18.00K 10-Q · filed 2025-11-04 | $18.00K derived: sum of 2 quarters · filed 2025-11-04 | $50.00K 10-Q · filed 2025-11-04 | $50.00K derived: sum of 4 quarters · filed 2026-02-19 |
| 2024-06-30 | $0.00 10-Q · filed 2025-08-05 | $32.00K 10-Q · filed 2025-08-05 | $32.00K derived: sum of 3 quarters · filed 2026-02-19 | $35.00K derived: sum of 4 quarters · filed 2026-02-19 |
| 2024-03-31 | $32.00K 10-Q · filed 2025-05-08 | $32.00K derived: sum of 2 quarters · filed 2026-02-19 | $35.00K derived: sum of 3 quarters · filed 2026-02-19 | $42.00K derived: sum of 4 quarters · filed 2026-02-19 |
| 2023-12-31 | $0.00 derived: 10-K 12 month − 10-Q/A 9 month · filed 2026-02-19 | $3.00K derived: sum of 2 quarters · filed 2026-02-19 | $10.00K derived: sum of 3 quarters · filed 2026-02-19 | -$26.00K 10-K · filed 2026-02-19 |
| 2023-09-30 | $3.00K 10-Q/A · filed 2024-11-18 | $10.00K derived: sum of 2 quarters · filed 2024-11-18 | -$26.00K 10-Q/A · filed 2024-11-18 | $12.00K derived: sum of 4 quarters · filed 2025-02-27 |
| 2023-06-30 | $7.00K 10-Q/A · filed 2024-11-18 | -$29.00K 10-Q/A · filed 2024-11-18 | $9.00K derived: sum of 3 quarters · filed 2025-02-27 | -$200.00K derived: sum of 4 quarters · filed 2025-02-27 |
| 2023-03-31 | -$36.00K 10-Q/A · filed 2024-11-18 | $2.00K derived: sum of 2 quarters · filed 2025-02-27 | -$207.00K derived: sum of 3 quarters · filed 2025-02-27 | -$198.00K derived: sum of 4 quarters · filed 2025-02-27 |
| 2022-12-31 | $38.00K derived: 10-K 12 month − 10-Q 9 month · filed 2025-02-27 | -$171.00K derived: sum of 2 quarters · filed 2025-02-27 | -$162.00K derived: sum of 3 quarters · filed 2025-02-27 | -$136.00K 10-K · filed 2025-02-27 |
| 2022-09-30 | -$209.00K 10-Q · filed 2023-11-09 | -$200.00K derived: sum of 2 quarters · filed 2023-11-09 | -$174.00K 10-Q · filed 2023-11-09 | -$177.00K derived: sum of 4 quarters · filed 2024-11-18 |
| 2022-06-30 | $9.00K 10-Q · filed 2023-08-11 | $35.00K 10-Q · filed 2023-08-11 | $32.00K derived: sum of 3 quarters · filed 2024-11-18 | $58.00K derived: sum of 4 quarters · filed 2024-11-18 |
| 2022-03-31 | $0.00 10-Q · filed 2023-05-11 | $23.00K derived: sum of 2 quarters · filed 2024-11-18 | $49.00K derived: sum of 3 quarters · filed 2024-11-18 | $141.00K derived: sum of 4 quarters · filed 2024-11-18 |
| 2021-12-31 | $23.00K derived: 10-K/A 12 month − 10-Q 9 month · filed 2024-11-18 | $49.00K derived: sum of 2 quarters · filed 2024-11-18 | $141.00K derived: sum of 3 quarters · filed 2024-11-18 | $141.00K 10-K/A · filed 2024-11-18 |
| 2021-09-30 | $26.00K 10-Q · filed 2022-11-03 | $118.00K derived: sum of 2 quarters · filed 2022-11-03 | $118.00K 10-Q · filed 2022-11-03 | |
| 2021-06-30 | $92.00K 10-Q · filed 2022-08-04 | $92.00K 10-Q · filed 2022-08-04 | ||
| 2020-12-31 | $0.00 10-K · filed 2023-03-02 | |||
| 2019-12-31 | $0.00 10-K · filed 2022-03-08 | |||
| 2018-12-31 | $0.00 10-K · filed 2021-03-18 | |||
| 2017-12-31 | $0.00 10-K · filed 2020-02-24 | |||
| 2016-12-31 | $0.00 10-K · filed 2019-03-07 | |||
| 2015-12-31 | $0.00 10-K · filed 2018-03-13 | |||
| 2014-12-31 | $0.00 10-K · filed 2017-03-23 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Structure Therapeutics Inc. (GPCR) | United States | $7.710B | -53.41 |
| Praxis Precision Medicines, Inc. (PRAX) | United States | $7.884B | -27.60 |
| IONIS PHARMACEUTICALS INC (IONS) | United States | $7.277B | -23.25 |
| Alkermes plc. (ALKS) | $6.844B | 132.74 | |
| RHYTHM PHARMACEUTICALS, INC. (RYTM) | United States | $6.771B | -37.20 |
| TG THERAPEUTICS, INC. (TGTX) | United States | $8.805B | 19.05 |
| Protagonist Therapeutics, Inc (PTGX) | United States | $8.883B | 95.52 |
| Liquidia Corp (LQDA) | United States | $6.347B | 51.23 |
| Amneal Pharmaceuticals, Inc. (AMRX) | $6.326B | 25.62 | |
| CYTOKINETICS INC (CYTK) | United States | $9.130B | -11.86 |